ABBV•Analysts raised target prices for AbbVie to $305 from $275, TransDigm Group to $1,350 from $1,300 and Visa to $486 from $475, among other rating and target changes for U.S.-listed companies.
Analysts revised ratings and price targets on dozens of U.S.-listed companies. Berenberg raised its AbbVie target to $305 from $275; TD Cowen raised its TransDigm Group target to $1,350 from $1,300, while RBC raised its target to $1,300 from $1,200; Bernstein raised its Visa target to $486 from $475.
The roundup also included target increases for companies including Constellation Energy, Primerica and Mastercard, and cuts for companies including CoreWeave, D-Wave Quantum and Toast. JPMorgan raised Republic Services to overweight from neutral and increased its target to $295 from $265.
